Mingjiu Chen

This inventor holds 10 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Biosion, Inc.. Active years: 2022-2026.

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 50.0

EPO Patents = 1 (Patent Applications = 17)

Average Co-Inventor Count = 2.1

ph-index = 1

Location History:

Nanjing, CN (2022)
Jiangsu, CN (2023)

Company Filing History:

10 out of 11

Biosion, Inc.

patents

Years Active: 2022-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735495 - ANTIBODIES BINDING IL4R AND USES THEREOF (2026-09-15),

2. 12723082 - MONOCLONAL ANTIBODIES WHICH BIND PD-1, ENCODING NUCLEOTIDES THEREOF AND METHOD OF USE THEREOF TO TREAT CANCER, INFECTIOUS DISEASE AND INFLAMMATORY DISEASE (2026-09-01),

3. 12715931 - NANOBODIES BINDING TROP2 AND USES THEREOF (2026-08-25),

4. 12703763 - ANTIBODIES BINDING C5 AND USES THEREOF (2026-08-11),

5. 12679900 - ANTIBODIES BINDING RANKL AND USES THEREOF (2026-07-14),

6. 12649789 - ANTIBODIES BINDING SIGLEC15 AND USES THEREOF (2026-06-09),

7. 12559565 - ANTIBODIES BINDING CTLA4 AND USES THEREOF (2026-02-24),

8. 12479912 - MONOCLONAL ANTIBODIES WHICH BIND THYMIC STROMAL LYMPHOPOIETIN (TSLP), ENCODING POLYNUCLEOTIDES THEREOF AND METHODS OF USE THEREOF TO TREAT DISEASES (2025-11-25),

9. 11739147 - Antibodies binding Siglec15 and uses thereof (2023-08-29),

10. 11390685 - ErbB2 antibodies and uses therefore (2022-07-19),

This text is generated by artificial intelligence and may not be accurate.